Hints and tips:
Related Special Reports
...Glaxo first bought Wellcome in 1995 and then SmithKline Beecham in 2000, becoming GSK. Glencore acquired Xstrata in 2013....
...It was under his successor, Sir Richard Sykes, that Glaxo undertook two major transactions — acquiring Wellcome in 1995 and merging with SmithKline Beecham in 2000 — which radically altered the portfolio...
...In the US, CVS pharmacies have limited purchases of children’s pain relief products to two per customer since last month....
...The move follows the announcement last year that Pret had received £100mn in funding from its owner JAB Holding and one of its founders Sinclair Beecham to double in size and expand into new markets....
...SmithKline Beecham (now part of GSK) pulled its successful Lyme disease vaccine in the early 2000s amid rising anti-vaccine sentiment....
...He pointed to the merger, almost 20 years ago, of Glaxo Wellcome with SmithKline Beecham, creating global behemoth GSK, which demonstrated that “the process was not as easily ‘industrialisable’ as people...
...“We look for people with a bigger vision, who can think in an unconstrained way, not limited by the original idea for their product.”...
...Nor have Glaxo and SmithKline Beecham. Telecoms groups have long claimed they need mergers to compete — most recently in the US and Europe....
...Beecham....
...Beecham to create GSK....
...A veteran of the pharmaceuticals industry, he experienced a big merger while working for SmithKline Beecham when it combined with Glaxo Wellcome in 2000....
...I was an investor in Glaxo Wellcome and SmithKline Beecham through most of the 1990s, before their merger into one entity....
...That was what happened in the last big round of consolidation, around the turn of the millennium, through Glaxo Wellcome’s merger with SmithKline Beecham and Pfizer’s with Warner-Lambert and Wyeth....
...He notes that Allergan was spun out of SmithKline in 1989 when it merged with Beecham....
...Glaxo began a programme of consolidation of the UK drug industry in the mid-nineties by first merging with Wellcome and, subsequently, with SmithKline Beecham....
...A Pfizer-AstraZeneca deal would rival the $74bn merger between GlaxoWellcome and SmithKline Beecham in 2000 as the biggest in industry history, and outstrip Pfizer’s own record $68bn acquisition of Wyeth...
...For much of the 20th century, the spectrum of interpretation was limited....
...Every Kenyan – it doesn’t matter where they are – their dreams and aspirations are resident in Nairobi,” says the pro-business Mr Kidero, once a managing director with SmithKline Beecham....
...Aside from its limited run-off and relative narrowness, it is the sheer length that makes it so difficult to adequately marshal and therefore highly dangerous....
...An MBA at Cranfield followed, and he landed a marketing job at SmithKline Beecham as assistant product manager of Instant Horlicks, a powdered drink....
...Others are following, with Glaxo SmithKline and Merck among the companies testing rival vaccines....
...As Glaxo Wellcome chief, he oversaw its merger with SmithKline Beecham in 2000, and stepped down in 2002 at the age of 60....
...He was also finance director at BG Group and chief financial officer at SmithKline Beecham, which merged with Glaxo Wellcome in 2000 to createGlaxoSmithKline....
...“It all depends what you mean by the people,” said Beecham....
...However, Mr Gumport concedes that the utility of his number-crunching, which relies on comparing the cost of buying back the shares to the most recent stock price, is “limited”....
International Edition